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Inpatient hospital performance is associated
with post‑discharge sepsis mortality
Nicholas M. Mohr1,2* , Alexis M. Zebrowski3 , David F. Gaieski3 , David G. Buckler3

and Brendan G. Carr4

Abstract
Background: Post-discharge deaths are common in patients hospitalized for sepsis, but the drivers of post-discharge
deaths are unclear. The objective of this study was to test the hypothesis that hospitals with high risk-adjusted inpatient sepsis mortality also have high post-discharge mortality, readmissions, and discharge to nursing homes.
Methods: Retrospective cohort study of age-qualifying Medicare beneficiaries with sepsis hospitalization between
January 2013 and December 2014. Hospital survivors were followed for 180-days post-discharge, and mortality, readmissions, and new admission to skilled nursing facility were measured. Inpatient hospital-specific sepsis risk-adjusted
mortality ratio (observed: expected) was the primary exposure.
Results: A total of 830,721 patients in the cohort were hospitalized for sepsis, with inpatient mortality of 20% and
90-day mortality of 48%. Higher hospital-specific sepsis risk-adjusted mortality was associated with increased 90-day
post-discharge mortality (aOR 1.03 per each 0.1 increase in hospital inpatient O:E ratio, 95% CI 1.03–1.04). Higher inpatient risk adjusted mortality was also associated with increased probability of being discharged to a nursing facility
(aOR 1.03, 95% CI 1.02–1.03) and 90-day readmissions (aOR 1.03, 95% CI 1.02–1.03).
Conclusions: Hospitals with the highest risk-adjusted sepsis inpatient mortality also have higher post-discharge
mortality and increased readmissions, suggesting that post-discharge complications are a modifiable risk that may be
affected during inpatient care. Future work will seek to elucidate inpatient and healthcare practices that can reduce
sepsis post-discharge complications.
Keywords: Sepsis, Quality of health care, Patient discharge, Patient readmission
Background
Sepsis is a life-threatening condition that affects 1.7 million Americans annually, with an in-hospital mortality of
16% [1]. Costing over $60 billion each year, sepsis is the
most expensive acute medical condition for which Medicare reimburses hospitals [2]. Early treatment has been
shown to improve survival to hospital discharge [1, 3, 4],
but sepsis case-fatality continues to vary significantly by
hospital (41% for highest-mortality decile of hospitals vs.
29% for lowest-mortality decile, p < 0.001) [5].
*Correspondence: nicholas‑mohr@uiowa.edu
1
Department of Emergency Medicine, University of Iowa Carver College
of Medicine, 200 Hawkins Drive, 1008 RCP, Iowa City, IA 52242, USA
Full list of author information is available at the end of the article

The burden of sepsis continues beyond hospital discharge. Many sepsis survivors have persistent neurocognitive deficits, neuromuscular weakness, symptoms of
depression and post-traumatic stress disorder, and poor
quality of life [6–10]. Readmissions after discharge are
common (21% within 30 days) [11], and sepsis survivors
have increased post-discharge mortality [12–14]. Postdischarge deaths have been associated with premorbid
health status and hospital factors [15, 16], but it is unclear
whether these factors are modifiable, and whether hospital care can alter the post-discharge course.
The objective of this study was to determine the
relationship between quality of hospital care (measured by hospital-specific inpatient adjusted sepsis survival) and post-discharge outcomes, including
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mortality, readmissions, and skilled nursing facility
discharge (Fig. 1). We postulate that hospitals that provide higher quality care have improved sepsis riskadjusted inpatient mortality and that this quality leads to
improved post-discharge mortality in those who survive
hospitalization. This analysis differs from prior work, in
that we are evaluating a primary exposure of hospital
performance (a more direct measure of hospital quality)
rather than administrative or epidemiologic factors than
may be related with quality indirectly, and our outcome
includes only those who survive hospitalization [15–18].
Such a relationship would suggest that the impact of
inpatient sepsis therapies may extend beyond hospital
discharge, and that early treatment elements may change
long-term immunity, organ function, and debility.

Methods
Study design, setting, and participants

This analysis was a retrospective cohort study of agequalifying Medicare beneficiaries with an emergency
department (ED)-based hospitalization in a U.S. hospital
for sepsis or septic shock between January 1, 2013 and
December 31, 2014. Hospital encounters were identified
using the Outpatient and Medicare Provider Analysis
and Review (MedPAR) research identifiable files from
the Centers for Medicare and Medicaid Services (CMS)
administrative claims data, while patient demographic
information and dates of death were obtained from the
Medicare Beneficiary Summary File and Vital Status
records. All cases were followed for 6 months after hospital admission, with deaths from any cause captured
through June 30, 2015 for the last-enrolling patients,
and readmissions for any cause censored on December
31, 2014 due to the years of Outpatient and MedPAR
data available. In-hospital mortality was estimated using
data from January 1, 2013 through December 31, 2014,
and these mortality estimates were used for calculating
observed-to-expected (O:E) mortality ratios for inclusion
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in subsequent explanatory models. Only hospitals with at
least 200 cases during the 2-year period were included in
the analysis to allow for more stable O:E ratio estimates.
This study was approved by the local institutional review
board (IRB) and is reported using the STrengthening
the Reporting of OBservational studies in Epidemiology
(STROBE) statement [20].
Definitions

Severe sepsis or septic shock was defined according to
International Classification of Diseases, 9th edition,
Clinical Modification (ICD-9-CM) diagnosis codes for
septicemia with an additional diagnosis for organ dysfunction, as previously reported [21–23]. Rural residence
was defined based on the county of residence, and was
classified according to the 2013 Rural–Urban Continuum Codes (RUCC) published by the U.S. Department
of Agriculture [24]. Comorbidities were defined using the
Elixhauser method, which identifies a set of 30 comorbid conditions from administrative data associated with
increased mortality, length-of-stay, and charges [25].
Index hospital was the first hospital where a patient was
seen for a given sepsis episode, while final hospital was
the last hospital where a patient was seen (to account for
patients transferred between hospitals for their care).
Exposures
Hospital‑specific mortality

The primary exposure was hospital-specific sepsis mortality. Hospital-specific sepsis mortality was reported as
an O:E mortality ratio based strictly on in-hospital mortality for the final hospital in which a patient was treated,
calculated for the study period 2013–2014. A multivariable logistic regression model was constructed with an
outcome of in-hospital mortality and a priori-defined
patient-level predictors, including age, race, sex, comorbidities, infection source, organ dysfunction, skilled nursing facility residence prior to admission, community

Fig. 1 Proposed causal diagram for the hypothesized relationship between hospital-specific observed:expected (O:E) mortality ratio and
post-discharge mortality. Shaded boxes indicate parameters that are measurable (non-shaded boxes are unmeasured). In our primary analysis,
we are using inpatient O:E mortality as a surrogate approximation of hospital quality. The purpose of this analysis is to understand to what degree
post-discharge mortality may be modifiable based on hospital-level care
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factors (percent Black, percent Hispanic, percent with
high school degree or higher, percent below poverty line),
ICU services in hospital, and teaching hospital. All variables were selected based on theory and the proposed
relationship with exposures and outcomes, and the same
adjustment variables were used for all models [5, 17, 26].
All continuous variables were modeled in categories,
and interactions were tested. The predicted probability
of mortality was generated for each case in the data set,
then the sum of observed in-hospital mortality and predicted in-hospital mortality for each facility was calculated. The ratio of the observed mortality to the predicted
mortality was the O:E ratio and was the primary predictor in this analysis.
Primary and secondary outcomes
Primary outcome

The primary outcome was 90-day post-discharge mortality, measured from the date of hospital discharge among
patients who survived their initial sepsis hospitalization.
The primary analysis used a hierarchical logistic regression model clustered on the final hospital with the primary exposure of hospital-specific O:E mortality ratio
and other potential patient and system-oriented confounders. Interactions were tested and all continuous
variables were coded into categorical groups. Covariates
for the model were selected based on prior data and possible confounders in patient-level, facility-level, and community-level variables.
Secondary analyses

Secondary analytic models were developed to measure
mortality at 30 days, 60 days, and 180 days post-discharge. A sensitivity analysis was performed using the
hospital O:E ratio for the index hospital, rather than the
final hospital, to determine if assigning ownership to the
first hospital changed the association with post-discharge
outcomes. Multivariable models were built similarly to
measure the association between hospital-specific predictors on hospital discharge to skilled nursing facility
(only among cases that did not reside in a skilled nursing
facility at the time of index admission) and readmission
within the first 90-days after discharge.
Sensitivity analysis
Survival models

An alternative approach was planned a priori to function
as a sensitivity analysis (if the impact of hospital mortality
on post-discharge mortality appeared preserved across
time, supporting the proportional hazards assumption): a
Cox proportional hazards model was developed with the
same set of covariates and an outcome of time-to-death,
among patients who survived the initial hospitalization.
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A second proportional hazards model was built for timeto-readmission among hospital survivors.
Unobserved confounder

An “E-value” was calculated to determine the minimum
strength of association required with both the predictor
and the outcome, for an unobserved confounder to render the coefficient of our primary exposure null. In this
way, we estimated how significant an unobserved variable would have to be for our results to be attributable
to confounding bias alone. To interpret this value, the
reader might conclude that a confounding variable not
included in the model would have to have an odds ratio
of at least this value for our findings to be a result of confounding alone.
Analysis

For all multivariable models, continuous predictor variables were categorized to avoid the linearity assumption,
interactions were tested for significance, and variables
were screened for multicollinearity. All analyses are done
using complete case analysis, and goodness of fit was
assessed using area under the curve (AUC) of the final
model. All statistical tests were considered significant for
p < 0.05 using two-tailed tests, and all analysis was conducted using Stata v.15.1. (StataCorp LLC, College Station, Texas).

Results
A total of 830,720 age-qualifying Medicare beneficiaries were hospitalized for sepsis between 2013 and 2014
(Fig. 2). We excluded 123,807 admissions in 1922 lowvolume hospitals with fewer than 200 cases during the
sample period. Most patients (68%) were hospitalized
with either a respiratory or urinary infection source,
14% had a co-existing malignancy, and 9% were admitted from a skilled nursing facility (Table 1). Of all cases,
1% were transferred between hospitals. In-hospital mortality was 20% (n = 167,854), with 30-day, 90-day, and
180-day cumulative mortality of 35% (n = 291,708), 43%
(n = 353,147), and 48% (n = 398,914), respectfully. Of
sepsis discharges, 37% (n = 247,045) were readmitted to
a hospital within 180 days, with the median time to readmission approximately 32 days (IQR 12–73 days).
Association between in‑hospital mortality
and post‑discharge mortality

The median index hospital O:E ratio was 1.00 (IQR 0.83–
1.17), with 1585 hospitals reporting at least 200 cases
over the 2-year period. O:E ratios ranged from 0.29 to
2.20 (IQR 0.83–1.17, Additional file 1: Fig. S1, Additional
file 2: Table S1). In univariable modeling, increasing hospital-specific O:E ratios were associated with increased
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CI 1.02–1.03). By 180-days after discharge, the adjusted
odds of readmission had decreased to 1.02 per 0.1
increase in O:E (95% CI 1.02–1.03).
Survival analysis

Fig. 2 Flow diagram of study subjects. Non-index sepsis encounters
include prior admissions, readmissions, transfers (at the receiving
hospital), and skilled nursing facility admissions

post-discharge mortality at 90-days (unadjusted OR 1.08
for each 0.1 increase in hospital-specific O:E ratio, 95%
CI 1.08–1.08). Controlling for potentially confounding
patient-, facility-, and community-level covariates, the
adjusted odds ratio showed a strong association between
hospital O:E ratios and mortality (aOR 1.03 for each 0.1
increase in hospital-specific O:E ratio, 95% CI 1.03–1.04).
The magnitude of effect was unchanged for mortality
from 30 to 180 days (Fig. 3, Additional file 3: Table S2).
Secondary outcomes

No differences were seen in the association between
index hospital O:E and 90-day post-discharge mortality
compared with the use of final hospital in the primary
models (aOR 1.03, 1.03–1.04). Of the 610,874 patients
that did not live in a nursing facility prior to their index
sepsis admission and who survived to discharge, 25%
(n = 153,378) were discharge to a SNF. Using a multivariable model similar to the primary model, patients from
hospitals with the highest O:E ratios had an increased
odds of being discharged to a skilled nursing facility (aOR 1.03 per 0.1 increase in O:E mortality ratio for
final hospital, 95% CI 1.02–1.03). Similarly, patients
from hospitals with the highest risk-adjusted mortality
also had increased probability of 90-day readmissions
(aOR 1.03 per 0.1 increase in O:E for final hospital, 95%

As a sensitivity analysis, a Cox proportional hazards
model was used to measure the time to death, accounting
for all the covariates from the logistic regression models
and the hospital O:E ratio (Fig. 3). The hazard ratio for
post-discharge mortality was higher in patients treated
in a hospital with a higher O:E ratio (aHR 1.02 per 0.1
increase in O:E for final hospital, 95% CI 1.02–1.03). A
“dose–response” relationship was seen between hospital
O:E and mortality with lower hazard for post-discharge
mortality in the lower categories of hospital O:E (reference group < 0.75; 0.75–1.00: aHR 1.01, 95% CI 1.00–1.01;
1.00–1.25: aHR 1.01, 95% CI 1.01–1.01; > 1.25: aHR 1.02,
95% CI 1.01–1.02). A Cox proportional hazards model
was also used to assess time to readmission. In adjusted
models, higher hospital O:E ratios were associated with
increased readmissions (aHR: 1.02 per 0.1 increase in O:E
for index hospital, 95% CI 1.02–1.03). For hospitals with
an O:E ratio > 1.25, median time to readmission within
the first 180 days after discharge was 30 days (IQR 11–69)
compared with 34 days in hospitals with an O:E < 0.75
(IQR 13–76).
In our sensitivity analysis to measure the theoretical
magnitude of an unobserved confounder (E-value), the
magnitude of bias introduced by an unmeasured variable
must have an odds of at least 2.05 (lower 95% CI 1.88).
A moderately strong predictor of both hospital O:E and
death at 90 days would be required to result in null findings (similar in magnitude to premorbid cancer diagnosis or nursing home residence). It seems unlikely that an
unobserved variable predicting mortality with a magnitude equal to nursing home residence exists.

Discussion
The relationship between sepsis and post-discharge
mortality has been well established [12–14, 27], but
whether post-discharge mortality has modifiable treatment-related risks remained unclear. This question has
been challenging to answer, since the specific biological
mechanisms by which post-sepsis mortality is elevated
have not been well elucidated. Mechanistic data suggest
that sepsis survivors remain immune suppressed [28,
29], have increased rates of atherosclerosis [13, 30], and
that epigenetic regulation may play a role in modulating
these effects [31]. The question that mechanistic studies
have not answered, however, is whether improved inpatient care can attenuate the impact on late post-discharge
mortality. By analyzing variation between U.S. hospitals,
our data suggests that it may.
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Table 1 Baseline characteristics of the study population
Characteristic

Descriptive statistics
All cases (n = 830,720)

Survived
to discharge
(n = 662,866)

n (%)

n (%)

Patient characteristics
Sex
  Male

393,852 (47.4)

314,824 (47.5)

  Female

436,868 (52.6)

348,042 (52.5)

  White

641,526 (77.2)

512,243 (77.3)

  Black

101,581 (12.2)

79,308 (12.0)

  Other

87,613 (10.6)

71,315 (10.8)

Race

Age
  65–74 years

274,021 (33.0)

225,032 (33.9)

  75–84 years

303,933 (36.6)

242,410 (36.6)

  85+ years

252,766 (30.4)

195,424 (29.5)

740,872 (89.2)

590,784 (89.1)

89,377 (10.8)

71,715 (10.8)

Urbanicity of residence (by RUCC code)
  Urban (metro counties)
  Rural (nonmetro counties)
  Other/unknown

471 (0.1)

367 (0.1)

Cancer diagnosis
  None

715,653 (86.2)

580,536 (87.6)

  Metastatic solid tumor

10,656 (1.3)

7,208 (1.1)

  Non-metastatic solid tumor

72,133 (8.7)

51,807 (7.8)

  Hematologic malignancy

32,278 (3.9)

23,315 (3.5)

Infection source
  Urinary tract

338,046 (40.7)

288,389 (43.5)

  Pneumonia

225,647 (27.2)

171,908 (25.9)
24,135 (3.6)

  Abdominal

33,433 (4.0)

  Bloodstream

26,217 (3.2)

22,148 (3.3)

  Cellulitis

24,288 (2.9)

21,407 (3.2)

  Bone

17,909 (2.2)

15,247 (2.3)

  Surgical

10,960 (1.3)

9329 (1.4)

  Ear, nose, throat

1240 (0.2)

1130 (0.2)

  Meningitis

1051 (0.1)

832 (0.1)

794 (0.1)

755 (0.1)

  Gastrointestinal
  Other/unknown

151,135 (18.2)

107,586 (16.2)

Organ dysfunction
  Renal

250,655 (30.2)

212,506 (32.1)

  Neurologic

227,220 (27.4)

177,610 (26.8)

  Metabolic

145,086 (17.5)

101,214 (15.3)

  Hematologic

73,996 (8.9)

61,618 (9.3)

  Cardiac

50,414 (6.1)

39,498 (6.0)

  Respiratory

41,985 (5.1)

35,072 (5.3)

  Hepatic

8396 (1.0)

5525 (0.8)

32,968 (4.0)

29,823 (4.5)

  No

759,098 (91.4)

618,575 (93.3)

  Yes

71,622 (8.6)

50,291 (7.6)

  Other/unknown
Admission from skilled nursing facility

Mohr et al. Crit Care

(2020) 24:626

Page 6 of 10

Table 1 (continued)
Characteristic

Descriptive statistics
All cases (n = 830,720)

Survived
to discharge
(n = 662,866)

n (%)

n (%)

Hospital characteristics
ICU services available
  No

10,409 (1.3)

8,633 (1.3)

  Yes

736,934 (88.7)

588,136 (88.7)

83,377 (10.0)

66,097 (10.0)

  Not reported/unknown
Council of teaching hospitals member
  No

675,249 (81.3)

541,556 (81.7)

  Yes

150,440 (18.1)

117,176 (17.7)

  Not reported/unknown

5031 (0.6)

4134 (0.6)

Community characteristics (zip code)
Percent of population unemployed
  0–5%

95,725 (11.5)

77,264 (11.7)

  6–8%

260,369 (31.3)

208,787 (31.5)

  9–11%

230,791 (27.8)

184,317 (27.8)

  12–15%

155,421 (18.7)

123,043 (18.6)

  ≥ 16%

88,414 (10.6)

69,455 (10.5)

Percent of population, black or African American
  0–1%

183,904 (22.1)

148,852 (22.5)

  2–3%

145,025 (17.5)

116,636 (17.6)

  4–5%

87,997 (10.6)

70,587 (10.6)

  6–10%

124,661 (15.0)

99,529 (15.0)

  11–20%

114,407 (13.8)

90,978 (13.7)

  21–40%

90,602 (10.9)

71,360 (10.8)

  ≥ 41%

84,124 (10.1)

64,924 (9.8)

Percent of population, Hispanic
  0–1%

90,385 (10.9)

72,473 (10.9)

  2–3%

153,434 (18.5)

123,561 (18.6)

  4–5%

106,717 (12.9)

85,911 (13.0)

  6–10%

156,509 (18.8)

124,846 (18.8)

  11–20%

136,061 (16.4)

108,231 (16.3)

  21–40%

101,608 (12.2)

803,78 (12.1)

  ≥ 41%

86,006 (10.4)

67,466 (10.2)

Percent of population, high school degree or higher
  0–20%

105,685 (12.7)

83,642 (12.6)

  21–25%

129,294 (15.6)

102,210 (15.4)

  26–28%

103,013 (12.4)

82,093 (12.4)

  29–33%

177,288 (21.3)

142,046 (21.4)
119,137 (18.0)

  34–38%

149,051 (17.9)

  39–45%

107,329 (12.9)

86,421 (13.0)

  ≥ 46%

59,060 (7.1)

47,317 (7.1)
128,113 (19.3)

Percent of population, below poverty line
  0–7%

159,421 (19.2)

  8–10%

118,812 (14.3)

95,364 (14.4)

  11–15%

183,827 (22.1)

147,216 (22.2)

  16–18%

91,917 (11.1)

73,484 (11.1)
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Table 1 (continued)
Characteristic

Descriptive statistics
All cases (n = 830,720)

Survived
to discharge
(n = 662,866)

n (%)

n (%)

  19–25%

152,570 (18.4)

121,147 (18.3)

  ≥ 26%

124,173 (15.0)

97,542 (14.7)

Fig. 3 Cox proportional hazard model curves showing adjusted time-to mortality (a) and time-to-readmission (b) for patients who survive a sepsis
hospitalization. Curves are stratified into cohorts defined by the quartile of observed:expected (O:E) in-hospital sepsis mortality aggregated at
the level of the hospital. Survival analysis is adjusted for age, race, sex, comorbidities, infection source, organ dysfunction, skilled nursing facility
residence prior to admission, community factors (percent Black, percent Hispanic, percent with high school degree or higher, percent below
poverty line), ICU services in hospital, teaching hospital

Inpatient quality can be difficult to measure [32, 33],
and the factors associated with sepsis quality are myriad
[34, 35]. The Early Management Bundle for Severe Sepsis/Septic Shock (SEP-1) [19] reported by the Centers for
Medicare and Medicaid Services is one parameter for
ranking hospitals on adherence with a single bundle of
very early care, but this measure is not a comprehensive
measure of sepsis quality of care and the specific causal
relationship between SEP-1 performance and outcomes
has been questioned [36–40]. By using an inclusive measure of risk-adjusted inpatient sepsis mortality aggregated
at the facility level, we have attempted to capture qualityof-care by its outcome. This study design cannot identify
which factors are associated with preventing late mortality or readmissions, but it provides evidence that care
factors that affect inpatient outcomes may continue to
influence patients after hospital discharge.
What factors might be responsible for the magnitude
of the association? Factors associated with post-discharge death could fall into one of four categories: early

resuscitation interventions, sub-acute organ support
and infection management, de-escalation of therapy, and
post-discharge planning and care coordination. Early
care interventions, such as timely antibiotics and hemodynamic resuscitation could decrease organ failure and
limit the degree of subclinical organ dysfunction persisting at hospital discharge. Immunomodulatory effects of
resuscitation may prevent both early organ failure and
persistent immune dysfunction [43].
The overall elements of care that are performed after
initial resuscitation, including antibiotic use and discontinuation, diuresis, early mobility, delirium management, nutrition, and other factors may also contribute to
sepsis outcomes [4, 44–46], but the specific manner in
which these practices function as predictors and effect
modifiers is not well described. Early mobility, timely
extubation, and delirium prevention strategies are welldescribed methods of decreasing mortality and disability from critical illness, and thus are attractive targets to
investigate in future studies [47–49]. Finally, discharge
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planning and care coordination may play a significant
role in post-discharge follow-up, access to care, medication management, and the transition to community living
[50]. Discharge planning, care coordination, and degree
of pre-discharge medical recovery also may explain
the relationship between inpatient O:E mortality, new
skilled nursing discharges, and readmissions, but none of
these elements were tested in our analysis. Gadre, et al.
recently reported readmissions after nearly 18% of sepsis
discharges, and they were associated with more comorbidities, longer index hospital stays, and residence in
skilled nursing facilities [51]. Although conclusive causal
relationships have not been established, one might predict that (1) providing high-quality sepsis care that limits deconditioning and chronic organ dysfunction, (2)
scheduling discharge timing and managing chronic disease well, and (3) developing strong relationships with
primary care providers, community organizations, and
post-acute care providers to provide a seamless postacute care transition may effectively limit the need for
both skilled nursing and readmissions.
This study has several limitations. First, our use of
observational data limits our statistical models to variables commonly recorded in administrative data, allowing for the possibility of unobserved confounders. These
available data also led to our use of hospital O:E mortality
as a surrogate for hospital quality—likely an incomplete
surrogate with some potential for residual confounding
and sensitive to differences in coding practices between
hospitals. Second, we included only Medicare beneficiaries in these data. While two-thirds of sepsis cases in the
U.S. are Medicare beneficiaries, using these cases alone
isolates a population over age 65 with reliable payment
for healthcare services.

Conclusions
In conclusion, hospitals with the lowest risk-adjusted
sepsis inpatient mortality also have reduced post-discharge mortality. These observations suggest that some
factors influencing in-hospital mortality also influence
post-discharge outcomes, and some of these factors may
be modifiable. Future work should focus on identifying
factors associated with post-discharge outcomes and
optimizing inpatient and transitional care to improve the
likelihood of functional long-term recovery.
Supplementary information
Supplementary information accompanies this paper at https://doi.
org/10.1186/s13054-020-03341-3.
Additional file 1: Figure S1. Distribution of Hospital Sepsis Observed:
Expected Mortality Ratio for Included Facilities.
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Additional file 2: Table S1. Hospital characteristics by observed to
expected (O:E) ratio of in-hospital mortality
Additional file 3: Table S2. Outcomes
Abbreviations
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